刘永蕊,刘静蕾,唐国栋.PDCD5基因与非小细胞肺癌的研究进展[J].中国肿瘤,2015,24(4):302-306. |
PDCD5基因与非小细胞肺癌的研究进展 |
Research Progress of PDCD5 in Non-small Cell Lung Cancer |
投稿时间:2014-09-10 |
DOI:10.11735/j.issn.1004-0242.2015.04.A011 |
|
 |
中文关键词: PDCD5 非小细胞肺癌 文献分析 |
英文关键词:PDCD5 non-small cell lung cancer literature review |
基金项目: |
|
摘要点击次数: 2311 |
全文下载次数: 1010 |
中文摘要: |
摘 要:程序性细胞死亡分子5(programmed cell death 5,PDCD5)作为一种重要的凋亡正调控分子,在许多疾病的发生发展过程中起着重要作用。PDCD5在肺癌、结直肠癌、卵巢癌、乳腺癌等多种恶性肿瘤细胞株、患者血清及其肿瘤组织中均有表达水平下降,而在骨关节炎、狼疮性肾炎、支气管哮喘等自身免疫性疾病中表达上调。大量的临床实验研究涉及了PDCD5与非小细胞肺癌之间的关系,全文就目前PDCD5与非小细胞肺癌的研究进展作一综述。 |
英文摘要: |
Abstract:Programmed cell death 5(PDCD5) is an important molecule related to apoptosis and plays important roles in the process of many diseases.PDCD5 was under-expression in a variety of lung cancer,colorectal cancer,ovarian cancer,breast cancer and other malignant tumor cells,serum and tumor tissue. However,PDCD5 was overexpressed in autoimmune disease,such as osteoarthritis,lupus nephritis,bronchial asthma. A large quantity of clinical experiments studies concern the relationship between PDCD5 and non-small cell lung cancer. The current research progress of PDCD5 and non-small cell lung cancer were reviewed in this paper. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|